Pharmacy Stocks
Compounded 4-aminopyridine CAS 504-24-5 Drug Intermediate in Organic Chemistry
2024-02-20 02:46  Visit:280
Price:Unfilled
Send inquiry
Production introduction

 

Compounded 4-aminopyridine CAS 504-24-5 can block voltage dependent potassium ion channels in other nerve membranes. 4-aminopyridine CAS 504-24-5 drug intermediate in organic chemistry is a K+channel blocker that can cause epileptic discharges in vitro experiments and is a potent convulsive agent in both animals and humans. 4-Aminopyridine, with the chemical formula C5H4N-NH2 and CAS (Chemical Abstracts Service) number 504-24-5, is a compound that belongs to the pyridine class of organic compounds. It is commonly referred to as 4-AP. Compounded 4-aminopyridine CAS 504-24-5 drug intermediate in organic chemistry aminopyridine medication have the Pharmacological Activity, Neurological Research, Treatment of Multiple Sclerosis (MS), Veterinary Medicine: It has also been explored for veterinary applications, particularly in the treatment of certain neurological conditions in animals.

 

Production specification

 

Name

CAS504-24-5

Other name

4-aminopyridine

Molecular formula

C5H6N2

Molecular weight

94.11

Capacity

1200/ ton

Fusing point

158-159℃

Properties

White to pale yellow crystals

Hydration

≤0.5%

Ash content

≤0.5%

Related substance

Liquid phase detection

2-aminopyridine

≤0.5%

3-aminopyridine

≤0.5%

Content

≥99%

 

FAQ

 

Q1: Can I get sample?

Re: Yes, Sample are available. Samples are for free.

Q2: Which payment ways is available for your company?

Re: T/T, L/C or trade insurance.You can choose the one which is convenient for you.

Q3: How to deliver the goods?

Re: It depend on your country, we provide the different shipping ways.

Q4: Is there any possible to use my appointed label or package?

Re: Yes. If needed.

Q5: How can you guarantee the goods you offer is qualified?

Re: We will have goods tested and relative certificate.

 

http://www.huarongpharma.com/

Message

TO: huarongzhiyao

E-mail:

Content:

Contact information
Comment
0